BRIEF-Roche Q4 China Sales Fell Amid Inventory Cuts, Sees 2020 Double-Digit Growth [Reuters]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Reuters
BRIEF-Roche Q4 China Sales Fell Amid Inventory Cuts, Sees 2020 Double-Digit Growth Jan 30 (Reuters) - Roche Holding AG: * ROCHE CEO SAYS IMPACT OF BIOSIMILARS ON HERCEPTIN, RITUXAN IS “WASHING OUT” IN EUROPE, WHERE ROCHE IS RETURNING TO GROWTH, SEES AVASTIN BIOSIMILARS HIT STARTING LATER THIS YEAR * ROCHE CEO SAYS CHINA DECLINED IN THE FOURTH QUARTER, AS THE COMPANY REDUCED INVENTORY LEVELS IN DISTRIBUTION CHAIN IN PHARMA, DIAGNOSTICS, SAYS UNDERLYING DEMAND REMAINS STRONG AND EXPECTS CONTINUED DOUBLE DIGIT GROWTH IN 2020 * ROCHE CEO SAYS CHINA DECLINED IN THE Q4, AS THE COMPANY REDUCED INVENTORY LEVELS IN DISTRIBUTION CHAIN IN PHARMA, DIAGNOSTICS, SAYS UNDERLYING DEMAND REMAINS STRONG AND EXPECTS CONTINUED DOUBLE-DIGIT GROWTH IN 2020 * ROCHE CEO SAYS EXPECTS TO GET SIGNIFICANT SHARE OF SPINAL MUSCULAR ATROPHY MARKET WITH RISDIPLAM, ITS ORAL MEDICINE WITH A MAY 24 FDA DECISION DATE * ROCHE CEO SAYS CORONOVIRUS AFFECTS ROCHE, EMPLOYEES LIKE ANY OTHER COMPANY OPERATING IN CHINA, SAYS HA
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Investors in Roche Holding (VTX:ROG) have unfortunately lost 18% over the last three years [Yahoo! Finance]Yahoo! Finance
- Managing Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) Found [Yahoo! Finance]Yahoo! Finance
- Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab) for the Treatment of Several Forms of HER2-Overexpressing Cancer [Yahoo! Finance]Yahoo! Finance
- Bonum Therapeutics to Present on its Novel Platform for Generating Conditionally Activated Targeted Therapies at Keystone Conference [Yahoo! Finance]Yahoo! Finance
- Alentis Appoints Alberto Toso Chief Scientific Officer [Yahoo! Finance]Yahoo! Finance